MyStelara. For patients who have been prescribed Stelara

Size: px
Start display at page:

Download "MyStelara. For patients who have been prescribed Stelara"

Transcription

1 MyStelara For patients who have been prescribed Stelara

2

3 MyStelara Welcome This Stelara Patient Pack has been given to you because your doctor has prescribed Stelara for the treatment of psoriasis, psoriatic arthritis or Crohn s disease. The pack has been designed to provide you with all the relevant information about your condition and what you can expect from your treatment and the homecare service available to you. Before starting your treatment, carefully read the patient information leaflet relevant to your prescribed dose of Stelara which is included in the Stelara medication package. If you have any questions or concerns about your treatment regime, contact your healthcare professional immediately, as they are the best people to help you with your queries. In this booklet you will find: MyTreatment 3 MyInformation 11 MyQuestions 15 MyHomecare 19 MyContacts 21 1

4

5 MyTreatment What is Stelara? 1 Stelara is a type of medicine called a monoclonal antibody. You may hear it referred to as a biologic (or biological treatment) used for the treatment of adult and adolescent psoriasis, psoriatic arthritis and Crohn s disease. Monoclonal antibodies are proteins that recognise and bind specifically to certain proteins in the body. Stelara belongs to a group of medicines called immunosuppressants. These medicines work by weakening part of the immune system. These proteins have to be injected into the body and cannot be taken in tablet form. Stelara is administered by subcutaneous injection, this means the injection is given just under the skin. The active substance in Stelara is called Ustekinumab. Who is Stelara used for? 1 Stelara is used to treat psoriasis, psoriatic arthritis and Crohn s disease in the following circumstances: Adult psoriasis: to treat moderate-to-severe plaque psoriasis in adult patients who cannot use, or did not respond to, other medicines used to treat plaque psoriasis, or phototherapy treatment. Adolescent psoriasis: to treat moderate to severe plaque psoriasis in adolescent patients who are from the age of 12 years and over, who are inadequately controlled by other systemic therapies or phototherapies, and who are intolerant to other systemic therapies or phototherapies. 3

6 MyStelara Patient Pack Adult psoriatic arthritis: to treat active psoriatic arthritis in adult patients when the response to other non-biological medicines has been inadequate. Adult Crohn s disease: to treat adult patients with moderately to severely active Crohn s disease in adult patients who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFalpha antagonist or have medical contraindications to such therapies. Recommended Dosing: Psoriasis and Psoriatic Arthritis Your doctor will decide how much Stelara you need to use and for how long. Always use this medicine exactly as your doctor has told you. Adult Psoriasis: In adults under 100kg, the recommended dose of Stelara is 45mg. In adults weighing more than 100kg the recommended dose of Stelara is 90mg. Adult Psoriatic Arthritis: In adults under 100kg, the recommended dose of Stelara is 45mg. Adults weighing more than 100kg, a dose of either 45mg or 90mg may be given Adolescent Psoriasis: Your doctor will decide how much Stelara you need to use and for how long. Always use this medicine exactly as your doctor has told you. Recommended Dosing: Crohn s Disease Your doctor will decide how much Stelara you need to use and for how long. Always use this medicine exactly as your doctor has told you. Stelara treatment is to be initiated with a single intravenous (IV) dose based on body weight (approximately 6 mg/kg). This is a once-off IV infusion which will take place in the hospital. Your healthcare professional or nurse specialist will discuss this in detail with you and organise a date and time for this to take place. Your first maintenance dose will be a 90mg of Stelara which will be administrated subcutaneously 8 weeks after the intravenous dose. 4

7 MyTreatment Following this you will be taking Stelara every 12 weeks unless directed otherwise by your healthcare professional. How is Stelara given? Stelara is given by injection under the skin surface (subcutaneously) and comes in a prefilled syringe or a vial. Your healthcare professional will decide which dose of Stelara is necessary for you based on if you are an adult or an adolescent, your weight at the time of injection and also if you have psoriasis, psoriatic arthritis or Crohn s disease. When you first start treatment, your doctor or nurse specialist may inject your Stelara for you. However, you and your doctor or nurse specialist may decide that you can inject your medicine yourself. In this case, you will be trained on how to inject, so that you learn the proper technique and minimise any discomfort from the needle. They will also discuss the MyStelara Homecare Programme with you and they may refer you to this service for your first injection. Should you wish to find out more information on the MyStelara Homecare Nurse Support Programme, refer to the MyHomecare section of this booklet. Injecting yourself with Stelara The following instructions for administration show you how to prepare and inject your Stelara treatment. It is important to refer to this if you are unsure of any of the steps involved in injections your Stelara treatment. Please note that you should never try to inject Stelara yourself until you have been shown the right way to self-administer the injections by your doctor or nurse specialist, or by the MyStelara Homecare Nurse. When you decide you are ready to self-inject your TCP nurse will take you through a simple training programme and sign to confirm that you are now an independent self-injector. It is recommended that you avail of the Sharps Collection service for the safe disposal of your used syringes. 5

8 MyStelara Patient Pack STEP 1: ALLOW THE PRODUCT TO WARM TO ROOM TEMPERATURE mins Take the carton containing your Stelara pre-filled syringe out of the refrigerator and allow the syringe to sit outside the carton for 30 minutes. This will let it come to room temperature. If you inject yourself with cold Stelara it will be uncomfortable. Check to make sure that the number of syringes and dosage are correct. TIP: Take the pre-filled syringe out of the carton and wait 30 minutes. STEP 2: CHECK THE PRE-FILLED SYRINGE Hold your Stelara pre-filled syringe by the body with the covered needle pointing upward. Make sure not to touch the needle guard activation clips. Check the syringe to make sure that it has not been damaged and that the expiration date has not passed. Make sure that the liquid is clear to slightly opalescent (having a pearl-like shine) and colourless to light yellow. Do not inject the liquid if it is cloudy or discoloured, or has any foreign particles in it. TIP: You may notice an air bubble this is normal. 6

9 MyTreatment STEP 3: GATHER THE SUPPLIES FOR YOUR INJECTION AND WASH YOUR HANDS Make sure you have all your injection supplies available including your Stelara pre-filled syringe, an antiseptic wipe, cotton ball or gauze and your sharps container for disposal of the used syringe. Wash your hands well with soap and warm water. TIP: Make sure everything is ready BEFORE you wash your hands and that you are able to sit down comfortably. STEP 4: PREPARE THE INFUSION SITE Good places for the injection are the upper thigh or around the stomach, but at least 5cm away from the belly button. Don t inject into an area of skin affected by psoriasis, if possible. Wipe the area you will inject with the antiseptic wipe. Do not touch this area again before giving the injection. TIP: If possible, choose an area of skin not affected by psoriasis. 7

10 MyStelara Patient Pack STEP 5: REMOVE THE NEEDLE COVER Hold the body of the pre-filled syringe with one hand and pull the needle cover straight off. Take care not to touch the needle or touch the plunger while removing the needle cover. You need to inject Stelara promptly after the needle cover has been removed. Do not remove the needle cover until you are ready to inject Stelara. TIP: You may notice a drop of liquid at the end of the needle - this is normal. STEP 6: POSITION THE SYRINGE Hold the body of your Stelara pre-filled syringe in one hand between your middle and index fingers and place your thumb on top of the plunger head. Make sure you don t pull back on the plunger at any time. Use your other hand to gently pinch the area of skin that you previously cleaned. TIP: Gently pinch the area of skin where you will inject Stelara and hold firmly. 8

11 MyTreatment STEP 7: INJECT THE PRODUCT Use a quick, dart-like motion to insert the needle into the pinched skin as far as it will go. Inject all of the medicine by using your thumb to push in the plunger until the plunger head is completely between the needle guard wings. When the plunger is pushed in as far as it will go, keep pressure on the plunger head. TIP: Count to 5 to ensure that the product is injected slowly. STEP 8: WITHDRAW THE NEEDLE AND SYRINGE Pull the needle and syringe out and let go of your skin. Slowly take your thumb off the plunger head. This will let the empty syringe move up until the entire needle is covered by the needle guard. TIP: Withdraw the needle and syringe carefully then let go of your skin. 9

12 MyStelara Patient Pack STEP 9: AFTER THE INJECTION Press an antiseptic wipe over the injection site for a few seconds after the injection. There may be a small amount of blood or liquid at the injection site, which is normal. Press a cotton ball or gauze over the injection site for about 10 seconds. Do not rub your skin. Put your used syringe in your sharps container. TIP: If needed, you can cover the injection site with a small adhesive bandage. STEP 10: YOU HAVE SUCCESSFULLY FINISHED YOUR INJECTION mins If your dose is 90 mg and you received two 45 mg syringes, you will need to give yourself a second injection within 5 minutes of the first one. Always choose a different body area if administering a second injection. 10

13 MyInformation Before starting Stelara Check with your doctor before starting treatment with Stelara if you have any of the following: LATEX SENSITIVITY/ALLERGY The needle cover of the pre-filled syringe contains latex rubber. This may cause severe allergic reactions in people who are sensitive to latex. Tell your doctor if you have ever had an allergic reaction to latex or developed any allergic reaction to the Stelara injection. INFECTIONS You must tell your doctor if you have any kind of infection, open cuts or sores, or if you have signs you might be getting an infection, as Stelara may make you less able to fight infections. Tell your doctor even if it is a very minor infection, or if you have any signs or symptoms that might make you think you might be getting an infection. Signs of infection (including tuberculosis) include fever, flu-like symptoms, night sweats, feeling tired or short of breath, cough which will not go away, blood tinged sputum, warm, red and painful skin, or a painful skin rash with blisters, burning when passing water, diarrhoea, vomiting. Signs of infections of the chest (lower respiratory tract infections) such as cough, mucus discharges, high temperature, dizziness, feeling a pressure or heaviness in your chest, shortness of breathing or breathing at an increased rate. Also blocking of nose, watering of nose and increased heartbeat can be the symptoms of lower respiratory tract infection. 11

14 MyStelara Patient Pack It is particularly important to tell your doctor or nurse specialist if you have an infection that will not go away or that keeps coming back. TUBERCULOSIS (TB) It is important to tell your doctor if you ever had TB or if you have recently been near anyone who might have TB or if you have visited any country where TB is common. Your doctor will examine will examine you for TB according to local regulations 3, to see if you have TB before you start your treatment. If your doctor thinks you are at risk of TB, you will be given medicine before you start your treatment with Stelara, and this TB treatment may continue during your treatment with Stelara. CANCER Please inform your doctor if you have ever had any type of cancer. Medicines like Stelara weaken part of the immune system. This may increase your risk of cancer. If you have any queries about this please discuss these with your doctor. OTHER THERAPIES Tell your doctor or nurse specialist if you are taking or have been prescribed an immunosuppressive medicine (a medicine that reduces your body s ability to fight infection) or phototherapy (when your body is treated with special types of ultraviolet (UV) light) while using Stelara. Stelara has an effect on your immune system and the combination of these therapies may increase the risk of diseases related to a weakened immune system. However, the combination of these therapies has not been studied in clinical trials. If you are not sure if any of the above applies to you, talk to your doctor, pharmacist or nurse specialist before starting treatment with Stelara. USING OTHER MEDICINES Stelara may affect other medicines and other medicines may affect Stelara. 12

15 MyInformation Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. Do not take any new medicines, herbal remedies, vitamins or other over the counter medicines without contacting your healthcare professional to discuss first. PREGNANCY AND BREAST-FEEDING Talk to your doctor if you are pregnant or are planning to become pregnant while using Stelara. The effects of this medicine on pregnant women and unborn babies are not known. Women who are able to have children are advised to avoid becoming pregnant and must use an effective method of contraception during treatment and for 15 weeks after your last injection with Stelara. Talk to your doctor if you are breast-feeding or if you plan to breast-feed while using Stelara. Your doctor will decide whether you should start treatment. DRIVING AND USING MACHINES Stelara should not affect your ability to drive or operate machines VACCINATIONS Tell your doctor if you have recently had or are going to have a vaccination. When should I not use Stelara? Do not use Stelara if any of the following apply: The expiry date has passed. You can find the expiry date on the label and the carton after EXP. The expiry date refers to the last day of that month. You know, or think, it may have been exposed to extreme temperatures (such as accidentally frozen or heated). The product has been shaken vigorously. Stelara is a clear to slightly opalescent (have a pearl-like shine), colourless to light yellow solution. The solution may contain a few small translucent or white particles of protein. Do not use if the liquid is discoloured, cloudy or you can see other foreign particles floating in it. 13

16 MyStelara Patient Pack Possible Side Effects WHAT POTENTIAL SIDE EFFECTS SHOULD I BE AWARE OF? 2 Like all medicines, Stelara may cause side effects, although not everybody gets them. Most side effects are mild to moderate. However, some people may experience more serious side effects that could require urgent treatment. Tell your doctor straight away if you notice any of the following serious side effects as you may need urgent medical treatment: Signs of an allergic reaction such as difficulty breathing or swallowing, low blood pressure, which can cause dizziness or light-headedness, swelling of the face, lips, mouth or throat, skin rash and hives. Signs of infection (including tuberculosis) such as fever, flu-like symptoms, night sweats, feeling tired or short of breath, cough which will not go away, blood tinged sputum, warm, red and painful skin, or a painful skin rash with blisters, burning when passing water, diarrhoea, vomiting. Signs of infections of the chest (lower respiratory tract infections) such as cough, mucus discharges, high temperature, dizziness, feeling a pressure or heaviness in your chest, shortness of breathing or breathing at an increased rate. Also blocking of nose, watering of nose and increased heartbeat can be the symptoms of lower respiratory tract infection. Shedding of skin, as an increase in redness and shedding of skin over a larger area of the body may be symptoms of erythrodermic psoriasis or exfoliative dermatitis. Reporting of Side Effects If you get any side effects, talk to your doctor, pharmacists or nurse. This includes any possible side effect not listed on the package leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL Dublin 2. Tel: ; Fax: ; website: ie; medsafety@hpra.ie and to Janssen-Cilag Ltd on

17 MyQuestions HOW DO I STORE STELARA? Keep Stelara out of the sight and reach of children. Keep your pre-filled Stelara syringes or vials in a fridge (2 8 C). Do not keep Stelara in the freezer. Keep the pre-filled syringes or vials in the outer carton to protect them from light. Do not shake the pre-filled syringes or vials as this may damage the medicine. Remove your treatment from the fridge 30 minutes before your injection so it can reach room temperature. WHAT IF I LEFT MY STELARA OUT OF THE FRIDGE? You should not use your dose of Stelara if it is left out of the fridge for more than 30 minutes. If you think you ve left your medicine out of the fridge longer than you should, place the vial or pre-filled syringe back in the fridge and contact your healthcare professional as soon as possible for advice. HOW DO I DISPOSE OF MY USED STELARA SYRINGE OR VIAL? Stelara is for single use only. Any unused product remaining in the syringe or vial should not be used and should be disposed of with the syringe and/or vial. Stelara pre-filled or empty vials should be placed in a puncture-resistant container, like a sharps container. Sharps bin waste collection service is available to everyone who has been prescribed Stelara. Please talk to your doctor for more information on the service. Sharps bins are delivered and collected every 12 months as part of the MyStelara Homecare Service. 15

18 MyStelara Patient Pack Antiseptic wipes and other supplies can be disposed of in your household waste. Any unused Stelara (e.g. pre-filled syringes that are unusable or past their expiry date, or any vials with some medicine left in them) should be disposed of with the syringe intact in a sharps container. HOW DO I TAKE STELARA WITH ME WHEN I TRAVEL? Your doctor will tell you how often to take your Stelara. When you are planning your trip, check your calendar to see when your next dose is due. You may find that you will be travelling during some of your dose-free days. This means you can leave your Stelara at home. Check your calendar or use the dosing wheel at the end of this booklet to see when your next dose is due to ensure you are fully prepared. If you need to travel when your Stelara dose is due, speak to your doctor and follow their recommendations. Air travel restrictions may mean that you need a doctor s letter before you can travel with your prescription medicines. Keep your doctor s letter and your Stelara in your handbag or carry-on luggage, and show the letter to airport security to let them know what you are carrying. Stelara will need to be kept at 2-8 C during your journey. You can use the free travel pack that you received from your pharmacist with your first dose. Speak to your pharmacist or prescriber about the best way to do this. Always store Stelara in a fridge when you get to your destination. 16

19 MyQuestions WHAT DO I NEED TO CHECK BEFORE TAKING MY INJECTION? Before you use your Stelara, you should check that: It hasn t passed its expiry date. You can find this on the label and the carton after EXP. The expiry date refers to the last day of that month. Do not use Stelara if the expiry date has passed. It hasn t been exposed to extreme temperatures. Do not use Stelara if you know, or think that it may have been accidentally frozen or heated. The product hasn t been shaken vigorously. If it has, do not use the dose. Ensure it looks as expected. Stelara is a clear to slightly opalescent (having a pearl-like shine), colourless to light yellow solution for injection. The solution may contain a few small translucent or white particles of protein. Do not use Stelara if the liquid is discoloured, cloudy or you can see other foreign particles floating in it. WHAT IF I USE MORE STELARA THAN RECOMMENDED? If you think you have used more Stelara than you should have, talk to a doctor or pharmacist straight away. If you can, take the outer carton of the medicine with you, even if it s empty. WHAT IF I FORGET TO USE STELARA? If you forget a dose, contact your doctor or pharmacist. Do not take a double dose to make up for a forgotten dose. CAN I STOP USING STELARA? If you would like to stop taking Stelara you should discuss this with your doctor first. He or she will advise you on the best way to do this. If you stop taking it, your symptoms may come back. If you have any questions on the use of this medicine, ask your doctor or pharmacist. 17

20 WHERE CAN I GET ADDITIONAL INFORMATION ON STELARA? If you have a question about your treatment, please read the Patient Information Leaflet or speak to your healthcare professional. WHAT DO I DO IF I HAVE SIDE EFFECTS? Speak to your doctor, pharmacist or nurse. Reporting of Side Effects If you get any side effects, talk to your doctor, pharmacists or nurse. This includes any possible side effect not listed on the package leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL Dublin 2. Tel: ; Fax: ; website: ie; medsafety@hpra.ie and to Janssen-Cilag Ltd on

21 MyHomecare The MyStelara Homecare Service has been developed to support individuals who have been prescribed Stelara for their psoriasis, psoriatic arthritis or Crohn s disease. The aim of the Stelara homecare service is to support you with your treatment on Stelara and to work with you to ensure that you become confident to self inject. A PERSONALISED HOMECARE SERVICE This personalised homecare service is designed to support you by making your treatment easy and convenient. Homecare Co-ordinator Once you have been registered with the MyStelara Homecare service by your doctor you will be assigned your own Homecare Co-ordinator. This person will contact you to explain the service, answer any questions you may have and book a time for your first nurse visit. Home Visits A fully qualified nurse will visit your home or workplace (if required) to talk you through your treatment with Stelara and to teach you how to self-inject with confidence. If you have any questions or concerns about your next scheduled visit, administration of Stelara or sharps waste bin collection please contact TCP on

22 Sharps Collection Once you have been trained to self-inject by a fully qualified TCP nurse you can avail of the sharps bin service. Please contact your TCP Homecare Co-ordinator to request delivery of a new sharps bin or collection of a full sharps bin on The MyStelara Homecare Service is free to all patients who have been prescribed Stelara. The service is offered by TCP Homecare (an independent Irish company) working in partnership with Janssen (the manufacturers of Stelara ).

23 MyContacts There are many support services available who offer advice, support and networking opportunities to meet other people with your condition: The Irish Skin Foundation Arthritis Ireland The Irish Society of Crohns & Colitis The Psoriasis Association The Psoriasis and Psoriatic Arthritis Alliance The British Association of Dermatologists International Federation of Psoriasis Associations European Federation of Psoriasis Associations European Academy of Dermatology and Venereology Psonet: European Registry of Psoriasis 21

24 References: 1. Stelara Summary of Product Characteristics. Available from 2. Stelara Patient Information Leaflet. Available from 3. Guidelines on the Prevention and Control of Tuberculosis in Ireland Available from For further information on Stelara contact Janssen Medical Information on October 2017 PHIR/STE/0916/0005a(2)

A guide for patients who have been prescribed Stelara

A guide for patients who have been prescribed Stelara guide for patients who have been prescribed Stelara Getting to know your ne w treatment This guide aims to provide you with useful information about your new treatment, Stelara. To help you understand

More information

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about STELARA (pronounced stel-ahr-uh). It does not contain all the

More information

GETTING COMFORTABLE WITH TAKING STELARA

GETTING COMFORTABLE WITH TAKING STELARA GETTING COMFORTABLE WITH TAKING STELARA Your easy-to-follow overview of self-injection This guide is a supplement to the full Instructions for Use. This guide is not intended to replace those instructions.

More information

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about STELARA (pronounced stel-ahr-uh). It does not contain all the

More information

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use. INSTRUCTIONS FOR USE STELARA (stel ar a) (ustekinumab) injection, for subcutaneous use Instructions for injecting STELARA using a prefilled syringe. Read this Instructions for Use before you start using

More information

Your Step-by-Step Guide

Your Step-by-Step Guide SC (abatacept): Your Step-by-Step Guide How to prepare, use and dispose of the ORENCIA prefilled ULTRASAFE PASSIVE TM syringe in 5 main steps ORENCIA (abatacept) is a registered trademark of Bristol-Myers

More information

Administering ORENCIA (abatacept): Your Step-by-Step Guide

Administering ORENCIA (abatacept): Your Step-by-Step Guide Administering ORENCIA (abatacept): Your Step-by-Step Guide How to prepare, use and dispose of the abatacept pre-filled syringe or ClickJect pre-filled pen in five steps 427UK1500866-01 Date of preparation:

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride) PACKAGE LEAFLET: INFORMATION FOR THE USER Clindamycin 300 mg Capsules Clindamycin (as hydrochloride) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA. PsA STELARA is a prescription medicine approved to treat adults 18 years and older with active psoriatic arthritis (PsA), either alone or with methotrexate. WHICH YOU ARE YOU? RECOGNIZE THE FOUR SIGNS

More information

Daktacort 2% / 1% w/w cream

Daktacort 2% / 1% w/w cream PACKAGE LEAFLET: INFORMATION FOR THE USER Daktacort 2% / 1% w/w cream Miconazole nitrate / hydrocortisone Daktacort is a registered trademark Read all of this leaflet carefully before you start using this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer PACKAGE LEAFLET: INFORMATION FOR THE USER Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer Amorolfine (as Amorolfine Hydrochloride) Read all of this leaflet carefully before you

More information

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine PACKAGE LEAFLET 1 Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution Acetylcysteine Read all of this leaflet carefully before you start using this medicine Keep this leaflet. You

More information

Instructions for use. Ixekizumab

Instructions for use. Ixekizumab Instructions for use Taltz 80 mg solution for injection in pre-filled pen Ixekizumab Before using your pre-filled pen: Important points to know Before you use the Taltz pre-filled pen, read and carefully

More information

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea PATIENT INFORMATION LEAFLET Alphaderm 1% & 10% w/w Cream hydrocortisone and urea Read all of this leaflet carefully before you start using this medicine Keep this leaflet. You may need to read it again.

More information

Instructions For Use

Instructions For Use Instructions For Use 1 subcutaneous injection Welcome This guide contains information on how to use Rebif Rebidose, a pre assembled, single use autoinjector that administers one dose of Rebif (interferon

More information

What is in this leaflet 1. What Dalacin Cream is and what it is used for

What is in this leaflet 1. What Dalacin Cream is and what it is used for Package leaflet: Information for the patient PFIZER Dalacin Cream 2% Clindamycin phosphate Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

1 What Gyno-Daktarin cream is and what it is used for

1 What Gyno-Daktarin cream is and what it is used for PACKAGE LEAFLET: INFORMATION FOR THE USER Gyno-Daktarin cream Miconazole nitrate Gyno-Daktarin is a registered trademark Read all of this leaflet carefully before you start using this medicine. Keep this

More information

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate) Package leaflet: Information for the patient ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate) Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Dalacin V Cream Clindamycin phosphate

Dalacin V Cream Clindamycin phosphate Dalacin V Cream Clindamycin phosphate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Dalacin V Cream. It does not contain all the available information.

More information

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml)

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml) Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml) Important Information The device is a single-dose disposable pen. It

More information

Occlusal 26%w/w cutaneous solution salicylic acid

Occlusal 26%w/w cutaneous solution salicylic acid Occlusal 26%w/w cutaneous solution salicylic acid Information for Patients Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription.

More information

Eumovate Ointment clobetasone butyrate

Eumovate Ointment clobetasone butyrate [GlaxoSmithKline Logo] Package Leaflet: Information for the User Eumovate Ointment clobetasone butyrate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

MEDICATION AND INJECTION ADMINISTRATION EDUCATIONAL BOOKLET FOR OVULATION INDUCTION

MEDICATION AND INJECTION ADMINISTRATION EDUCATIONAL BOOKLET FOR OVULATION INDUCTION MEDICATION AND INJECTION ADMINISTRATION EDUCATIONAL BOOKLET FOR OVULATION INDUCTION Comprehensive Guide to Understanding, Mixing, and Administering Fertility Medications IMPORTANT PHONE NUMBERS: WEEKEND

More information

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene Package leaflet: Information for the user ZORAC 0.05% gel ZORAC 0.1% gel Tazarotene Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr TRAVATAN Z Travoprost Ophthalmic Solution Read this carefully before you start taking TRAVATAN Z and each time you

More information

ISOTREX GEL Isotretinoin 0.05% w/w

ISOTREX GEL Isotretinoin 0.05% w/w ISOTREX GEL Isotretinoin 0.05% w/w Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use Isotrex Gel. This leaflet answers some common questions about

More information

Instructions for Use BYDUREON (by-dur-ee-on) Single-Dose Tray (exenatide extended-release) for injectable suspension

Instructions for Use BYDUREON (by-dur-ee-on) Single-Dose Tray (exenatide extended-release) for injectable suspension BYDUREON (exenatide extended-release) for injectable suspension 6 Instructions for Use BYDUREON (by-dur-ee-on) Single-Dose Tray (exenatide extended-release) for injectable suspension Before using Bydureon,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost PACKAGE LEAFLET: INFORMATION FOR THE USER TRAVATAN 40 micrograms/ml eye drops, solution Travoprost Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox Package leaflet: Information for the patient Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox [For medicines available only on prescription] Read all of this leaflet carefully before you start

More information

Retin-A 0.05% w/w cream

Retin-A 0.05% w/w cream PACKAGE LEAFLET: INFORMATION FOR THE USER Retin-A 0.05% w/w cream Tretinoin Retin-A is a registered trademark Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION EMLA Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about EMLA. It does not contain all the information

More information

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide Package leaflet: Information for the patient Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Dermovate Ointment clobetasol propionate

Dermovate Ointment clobetasol propionate Dermovate Ointment clobetasol propionate Package Leaflet: Information for the User Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

TRANSGENDER HEALTH Injection Guide

TRANSGENDER HEALTH Injection Guide TRANSGENDER HEALTH Injection Guide 1of the Southern Finger Lakes This information in this booklet has been adapted with permission from a handbook created by Fenway Health. Fenwayhealth.org The instructions

More information

Medications and Medication Safety

Medications and Medication Safety Specialty Pharmacy Welcome Packet Medications and Medication Safety Address: 9605 57th Avenue Corona, NY 11368 844-334-9615 toll-free phone 844.941.4111 toll-free fax Website http://www.21centurypharmacy.com/

More information

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide Package leaflet: Information for the user Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Dermovate Scalp Application clobetasol propionate

Dermovate Scalp Application clobetasol propionate Dermovate Scalp Application clobetasol propionate Package Leaflet: Information for the user Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Eumovate Cream clobetasone butyrate

Eumovate Cream clobetasone butyrate Package leaflet: Information for the user Eumovate Cream clobetasone butyrate Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

More information

DP Fusidic Acid Cream

DP Fusidic Acid Cream New Zealand Consumer Medicine Information DP Fusidic Acid Cream Fusidic Acid 20 mg/g (2 %) Cream What is in this leaflet Please read this leaflet carefully before you start using DP Fusidic Acid Cream.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine Medicinal product name Outline PACKAGE LEAFLET: INFORMATION FOR THE USER CURANAIL 5%, medicated nail lacquer Amorolfine Read all of this leaflet carefully before you start using this medicine because it

More information

Dermovate Scalp Application clobetasol propionate

Dermovate Scalp Application clobetasol propionate Dermovate Scalp Application clobetasol propionate Package Leaflet: Information for the User Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine Package leaflet: Information for the user Versatis 700 mg medicated plaster Lidocaine Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults. New Zealand Consumer Medicine Information Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults. Read all of this leaflet carefully before you start using this medicine. This medicine

More information

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine PATIENT INFORMATION LEAFLET AMETOP GEL 4% w/w Tetracaine Read this entire leaflet carefully because it contains important information for you. This medicine is available without prescription. However,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5% PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5% Read all of this leaflet carefully before you or your child start using this medicine.

More information

Migraine Attack Abortive Treatment Medication Overuse Protocol Treatment Refractory Cluster Headache Treatment

Migraine Attack Abortive Treatment Medication Overuse Protocol Treatment Refractory Cluster Headache Treatment D i h y d r o e r g o t a m i n e ( D H E ) S u b c u t a n e o u s I n j e c t i o n G u i d e Migraine Attack Abortive Treatment Medication Overuse Protocol Treatment Refractory Cluster Headache Treatment

More information

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea PATIENT INFORMATION LEAFLET Hydromol HC Intensive Hydrocortisone and urea Read all of this leaflet carefully before you start using this medicine Keep this leaflet. You may need to read it again. If you

More information

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen) Information supplied only on request from a healthcare professional by: CRAWFORD HEALTHCARE LTD Unit 1, Adams Court Adams Hill Knutsford Cheshire WA16 6BA PATIENT INFORMATION LEAFLET PUVA TREATMENT If

More information

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate) ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate) PATIENT INFORMATION LEAFLET Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

A GUIDE TO STARTING STELARA

A GUIDE TO STARTING STELARA A GUIDE TO STARTING STELARA 1 PRESCRIBE STELARA FOR CROHN S DISEASE 2 3 VERIFY PATIENT INSURANCE BENEFITS START STELARA WITH IV INDUCTION AND SUBQ MAINTENANCE For the treatment of adults with moderately

More information

How to Give a Subcutaneous (SC) Injection to Your Child

How to Give a Subcutaneous (SC) Injection to Your Child How to Give a Subcutaneous (SC) Injection to Your Child Supplies: Needles and syringes Alcohol swabs and gauze Vial with the drug solution Sharps container (Health Facts for You #4587) Band-Aids Distraction

More information

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w CONSUMER MEDICINE INFORMATION What is in this leaflet? This leaflet answers some common questions about Hydrozole Cream. It does

More information

Instructions for Use. (dulaglutide) injection, for subcutaneous use. 1.5 mg/0.5 ml Single-Dose Pen. once weekly. Unfold and lay flat

Instructions for Use. (dulaglutide) injection, for subcutaneous use. 1.5 mg/0.5 ml Single-Dose Pen. once weekly. Unfold and lay flat 1 BREAK SEAL Instructions for Use TRULICITY (Trū-li-si-tee) BREAK SEAL (dulaglutide) injection, for subcutaneous use 1.5 mg/0.5 ml Single-Dose Pen once weekly Unfold and lay flat Read both sides for full

More information

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container Tafluprost Read all of this leaflet carefully before you start using this medicine because

More information

Package Leaflet: Information for the User

Package Leaflet: Information for the User GSK Logo Package Leaflet: Information for the User Betnovate Lotion betamethasone valerate Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate Package Leaflet: Information for the User Betnovate Scalp Application betamethasone valerate Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam minoxidil Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

Daivobet 50/500 gel Dye-vo-bet

Daivobet 50/500 gel Dye-vo-bet Dye-vo-bet Calcipotriol (Kal-sippo-try-all)/ Betamethasone (Beet-ah-meth-ah sown ) Consumer Medicine Information Please read this leaflet carefully before you start your treatment. Daivobet 50/500 gel

More information

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate DUAL ACTION LOGO Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide Package leaflet: Information for the patient Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide Read all of this leaflet carefully before you start using this medicine because

More information

Patient Information Leaflet. Dermal Filler

Patient Information Leaflet. Dermal Filler Patient Information Leaflet Dermal Filler When considering treatment with dermal fillers we want you to have a safe treatment. Some risks are unavoidable and out of your control. The following information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5% PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5% Read all of this leaflet carefully before you or your child start using this medicine.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w PACKAGE LEAFLET: INFORMATION FOR THE USER Isotrex Gel isotretinoin 0.05% w/w Read all of this leaflet carefully before you start using this medicine because it contains important information for you. -

More information

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp This medicine is used to treat hereditary hair loss in men aged 18 65 years. This product is for men only and should NOT be

More information

NEW PHASE 3 STELARA (USTEKINUMAB) DATA SHOW POSITIVE RESULTS AS MAINTENANCE THERAPY IN ADULTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

NEW PHASE 3 STELARA (USTEKINUMAB) DATA SHOW POSITIVE RESULTS AS MAINTENANCE THERAPY IN ADULTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS News Release Media Contact: Kellie McLaughlin +1 (609) 468-8356 (mobile) Investor Contacts: Chris DelOrefice +1 (732) 524-2955 (office) Lesley Fishman +1 (732) 524-3922 (office) NEW PHASE 3 STELARA (USTEKINUMAB)

More information

PATIENT INFORMATION LEAFLET. Timodine Cream

PATIENT INFORMATION LEAFLET. Timodine Cream PATIENT INFORMATION LEAFLET Timodine Cream Read all of this leaflet carefully before you start using this medicine Keep this leaflet. You may need to read it again. If you have any further questions, ask

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION ACZONE (dapsone 7.5% w/w) topical gel January 2017 V 1.0 1 ACZONE gel (dapsone 7.5% w/w) Consumer Medicine Information What is in this leaflet This leaflet answers some common

More information

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin Package leaflet: Information for the user Acnatac 10 mg/g + 0.25 mg/g gel clindamycin and tretinoin Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Do not take Neulasta if you have had a serious allergic reaction to pegfilgrastim (Neulasta ) or to filgrastim (Neupogen ).

Do not take Neulasta if you have had a serious allergic reaction to pegfilgrastim (Neulasta ) or to filgrastim (Neupogen ). {SIDE 1 Information} Patient Instructions for Use On-body Injector for Neulasta Description The on-body injector for Neulasta is intended for delivery of Neulasta. The on-body injector is small, for one-time

More information

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees 139.7mm 69.85mm 69.85mm EX50085 130.2mm 2% w/v Cutaneous Solution Minoxidil Hereditary hair loss treatment. MEDICALLY PROVEN TO STOP THINNING HAIR AND ADVANCED BALDNESS. PATIENT INFORMATION LEAFLET Warning

More information

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine Package leaflet: Information for the user Vaniqa 11.5% cream Eflornithine Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep

More information

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g CANESTEN PLUS Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g What is in this Leaflet This leaflet answers some common questions about CANESTEN PLUS Clotrimazole and Hydrocortisone Cream. It

More information

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin Package leaflet: Information for the user Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin Read all of this leaflet carefully before you start using this medicine because it

More information

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm Healthcare (Ireland) Ltd. 139.7mm 69.85mm 69.85mm EX50094 130.2mm 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN USER INFORMATION LEAFLET Inside Cover t: +44 (0)1440 766 500 w: www.starfishbrandsolutions.com

More information

Treatment Systemic Therapy. Your Guide to Subcutaneous Chemotherapy Self Injection

Treatment Systemic Therapy. Your Guide to Subcutaneous Chemotherapy Self Injection Treatment Systemic Therapy Your Guide to Subcutaneous Chemotherapy Self Injection Table of Contents 1 Gather your supplies 2 Setting up for your self-injection 3 Preparing the injection 5 Choosing and

More information

A GUIDE TO STARTING STELARA

A GUIDE TO STARTING STELARA A GUIDE TO STARTING STELARA 1 PRESCRIBE STELARA FOR CROHN S DISEASE 2 3 VERIFY PATIENT INSURANCE BENEFITS START STELARA WITH IV INDUCTION AND SUBQ MAINTENANCE For the treatment of adults with moderately

More information

State of Kuwait Ministry of Health Infection Control Directorate SAFE INJECTION

State of Kuwait Ministry of Health Infection Control Directorate SAFE INJECTION State of Kuwait Ministry of Health Infection Control Directorate SAFE INJECTION May 2010 Contents I. Introduction II. Prevention strategies III. Best practices for injection A. General safety practices

More information

ACETOCAUSTIN 0,5 ml, Cutaneous solution

ACETOCAUSTIN 0,5 ml, Cutaneous solution PACKAGE LEAFLET: INFORMATION FOR THE USER ACETOCAUSTIN 0,5 ml, Cutaneous solution MONOCHLOROACETIC ACID This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w Consumer Medicine Information What is in this leaflet? This leaflet answers some common questions about Hydroform Cream 1%. It

More information

Dermovate Ointment clobetasol propionate

Dermovate Ointment clobetasol propionate Dermovate Ointment clobetasol propionate Package Leaflet: Information for the user Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil Package leaflet: Information for the user Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam Minoxidil Read all of this leaflet carefully before you start using this medicine because it contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine PACKAGE LEAFLET: INFORMATION FOR THE USER Vaniqa 11.5% cream Eflornithine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. -

More information

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard Package leaflet: Information for the patient Clindamycin ABR 150 mg capsules, hard Clindamycin ABR 300 mg capsules, hard Clindamycin ABR 600 mg capsules, hard Clindamycin Read all of this leaflet carefully

More information

Psoralen Tablets (Methoxypsoralen)

Psoralen Tablets (Methoxypsoralen) Psoralen Tablets (Methoxypsoralen) Psoralen (Methoxypsoralen) Tablets This information is intended to provide you with information about your treatment and should be read thoroughly so that you are aware

More information

O N C E A DAY. In this leaflet FOR WOMEN

O N C E A DAY. In this leaflet FOR WOMEN FOR WOMEN O N C E A DAY Regaine for Women ONCE A DAY Scalp Foam Minoxidil 5% This medicine is used to treat female pattern hair loss in women aged 18 65 years. This product should only be used ONCE A DAY.

More information

A STEP-BY-STEP GUIDE TO GETTING STARTED WITH STELARA

A STEP-BY-STEP GUIDE TO GETTING STARTED WITH STELARA A STEP-BY-STEP GUIDE TO GETTING STARTED WITH STELARA What You Can Expect Now that you and your doctor have decided on STELARA, it s time to engage your team, from healthcare provider to specialty pharmacy

More information

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Read this carefully before you start taking PENTAMYCETIN each time you get a refill. This leaflet is a summary and will

More information

Hair Loss Treatment Regular Strength (Minoxidil)

Hair Loss Treatment Regular Strength (Minoxidil) Information for the user Hair Loss Treatment Regular Strength (Minoxidil) Read all of this leaflet carefully before you take this medicine because it contains important information you need to know. This

More information

Lenis Needle-free Safety Syringe Device User Manual

Lenis Needle-free Safety Syringe Device User Manual Lenis Needle-free Safety Syringe Device User Manual 1 Table of Contents Welcome.3 Lenis Kit Components.4 Instructions 5-9 Maintenance and Care..10 Troubleshooting. 11 Warranty.12 Precautions 13 Return

More information

Information PROPECIA Finasteride 1mg Tablet

Information PROPECIA Finasteride 1mg Tablet Information PROPECIA Finasteride 1mg Tablet What Propecia is used for PROPECIA is for use by men only. PROPECIA is used to treat men with male pattern hair loss to increase hair growth on the scalp and

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine Medicinal product name Outline PACKAGE LEAFLET: INFORMATION FOR THE USER CURANAIL 5%, medicated nail lacquer Amorolfine Read all of this leaflet carefully before you start using this medicine because it

More information

HOW TO USE. and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment

HOW TO USE. and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment HOW TO USE and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment TARGRETIN gel should not be used by women who are pregnant, believe they may be pregnant, or are planning to become pregnant.

More information

Whole body PUVA treatment. Information for patients Dermatology

Whole body PUVA treatment. Information for patients Dermatology Whole body PUVA treatment Information for patients Dermatology What is PUVA? PUVA is a type of artificial light treatment that is used to treat many different skin conditions, especially psoriasis and

More information

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January PACKAGE LEAFLET EN Elastoplast Heat Plaster 11 mg January 2013 1 Package leaflet: Information for the user Elastoplast Heat Plaster11 mg medicated Plaster Soft extract of cayenne pepper (equiv. to 11 mg

More information

STELARA TM (ustekinumab) 30 December, 2009

STELARA TM (ustekinumab) 30 December, 2009 STELARA TM (ustekinumab) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA.

More information

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine Package leaflet: Information for the user Cream 5% (for 30 g surgical packs) lidocaine/prilocaine Read all of this leaflet carefully before you or your child start using this medicine because it contains

More information

WOMEN'S Regaine EXTRA STRENGTH

WOMEN'S Regaine EXTRA STRENGTH WOMEN'S Regaine EXTRA STRENGTH MINOXIDIL 5% W/W TOPICAL FOAM Consumer Medicine Information Please read this booklet carefully. It will help you understand how to use Foam and what to expect from its use.

More information

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult) Application of Prescribed Creams/ Ointments/ Lotions (Adult) CLINICAL GUIDELINES ID TAG Medicines Management Specific Title: Procedure: Application of prescribed Creams/ Ointments/ Lotions (Adult) Author:

More information

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen n The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen Information for patients Your doctor has referred you for a course of PUVA treatment for your skin condition. This

More information

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Why should you self-care? How can my local pharmacist help? How your pharmacist can help Be self-care aware Many common illnesses or symptoms are best treated at home with rest or with advice from a community pharmacist with no need to see a doctor or nurse. This leaflet contains advice and

More information